Deutsche Bank
VRTX icon

Deutsche Bank’s Vertex Pharmaceuticals VRTX Stock Holding History

Deutsche Bank’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-65
Closed -$14K – 4858
2019
Q4 		$14K Hold
65
– – ﹤0.01% 4412
2019
Q3 		$11K Hold
65
– – ﹤0.01% 4485
2019
Q2 		$11K Hold
65
– – ﹤0.01% 4958
2019
Q1 		$11K Hold
65
– – ﹤0.01% 4910
2018
Q4 		$10K Sell
65
-269
-81% -$46.6K ﹤0.01% 4879
2018
Q3 		$65K Buy
334
+269
+414% +$47.9K ﹤0.01% 4634
2018
Q2 		$11K Hold
65
– – ﹤0.01% 5138
2018
Q1 		$10K Buy
+65
New +$10.6K ﹤0.01% 5149
2017
Q3 		– Sell
-129
Closed -$16K – 5106
2017
Q2 		$16K Buy
+129
New +$15.5K ﹤0.01% 4606
2015
Q1 		– Sell
-1,600
Closed -$190K – 5997
2014
Q4 		$190K Hold
1,600
– – ﹤0.01% 4336
2014
Q3 		$179K Sell
1,600
-7,002
-81% -$667K ﹤0.01% 4140
2014
Q2 		$814K Buy
8,602
+1,992
+30% +$140K ﹤0.01% 3103
2014
Q1 		$25K Sell
6,610
-26,556
-80% -$2.1M ﹤0.01% 4776
2013
Q4 		$564K Sell
33,166
-3,400
-9% -$237K ﹤0.01% 3021
2013
Q3 		$781K Buy
36,566
+4,764
+15% +$379K ﹤0.01% 3164
2013
Q2 		$872K Buy
+31,802
New +$2.34M ﹤0.01% 2791

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Deutsche Bank's VRTX Position: Q1 2026 in Review

Deutsche Bank reduced its Vertex Pharmaceuticals (VRTX) stake by 13% in Q1 2026, selling an estimated $108M and leaving 1,537,736 shares worth $687M. The position accounts for 0.23% of the portfolio, ranked #92.

Deutsche Bank first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. The position peaked at $802M in Q4 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Deutsche Bank held 1,537,736 shares of Vertex Pharmaceuticals worth $687M as of Q1 2026.
  • Deutsche Bank sold 231,145 Vertex Pharmaceuticals shares in Q1 2026, an estimated $108M.
  • Vertex Pharmaceuticals made up 0.23% of Deutsche Bank's portfolio in Q1 2026, its #92 holding.
  • Deutsche Bank first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • Deutsche Bank's Vertex Pharmaceuticals position peaked at $802M in Q4 2025.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.